Siomycin A treatment in prostate cancer cell lines PC3 and LNCaP

ABSTRACT: Siomycin A treatment in prostate cancer cell lines resulted in a concurrent inhibition of specific cell cycle genes and strongly impaired cell viability. Illumina microarray experiments were done using PC3 and LNCaP cell lines treated with 0.5 microM Siomaycin A either 24h or 48h in triplicates.

ORGANISM(S): Homo sapiens

SUBMITTER: Ruprecht Kuner 

PROVIDER: E-GEOD-36531 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress